Including Adverse Drug Events in Economic Evaluations of Anti-Tumour Necrosis Factor-α Drugs for Adult Rheumatoid Arthritis: A Systematic Review of Economic Decision Analytic Models

Adult Rheumatoid Arthritis ◽

Factor Α ◽

Analytic Models ◽

Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-200490 ◽

2012 ◽

Vol 71 (8) ◽

pp. 1303-1308 ◽

Cited By ~ 74

Author(s):

Monika Schoels ◽

Daniel Aletaha ◽

Josef S Smolen ◽

John B Wong

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Comparative Effectiveness ◽

Tumour Necrosis ◽

Biological Treatment ◽

Meta Analysis ◽

Treatment Options ◽

Factor Α ◽

Management of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis

Rheumatology ◽

10.1093/rheumatology/kev364 ◽

2015 ◽

pp. kev364 ◽

Cited By ~ 4

Author(s):

Susan M. Goodman ◽

Indu Menon ◽

Paul J. Christos ◽

Rie Smethurst ◽

Vivian P. Bykerk

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Meta Analysis ◽

Factor Α ◽

Faculty Opinions recommendation of Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717951123.793456424 ◽

2012 ◽

Author(s):

David Scott ◽

Nicola Gullick ◽

Margaret Ma

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Comparative Effectiveness ◽

Tumour Necrosis ◽

Biological Treatment ◽

Meta Analysis ◽

Treatment Options ◽

Factor Α ◽

Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

Rheumatology International ◽

10.1007/s00296-009-1012-6 ◽

2009 ◽

Vol 30 (7) ◽

pp. 977-978 ◽

Cited By ~ 4

Author(s):

Erika Angelucci ◽

Monica Cesarini ◽

Piero Vernia

Keyword(s):

Rheumatoid Arthritis ◽

Myasthenia Gravis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Immunosuppressive Drugs ◽

Concomitant Treatment ◽

Successful Resolution ◽

Factor Α ◽

FLOW CYTOMETRICAL DETERMINATION OF INTERLEUKIN 1β, INTERLEUKIN 6 AND TUMOUR NECROSIS FACTOR α IN MONOCYTES OF RHEUMATOID ARTHRITIS PATIENTS; RELATION WITH PARAMETERS OF OSTEOPOROSIS

Cytokine ◽

10.1006/cyto.1998.0500 ◽

1999 ◽

Vol 11 (11) ◽

pp. 869-874 ◽

Cited By ~ 12

Author(s):

Ann Verbruggen ◽

Luc S De Clerck ◽

Chris H Bridts ◽

Jan F Van Offel ◽

Wim J Stevens

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Interleukin 1Β ◽

Factor Α ◽

The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs—BioRx.si

Clinical Rheumatology ◽

10.1007/s10067-018-4324-7 ◽

2018 ◽

Vol 38 (2) ◽

pp. 297-305 ◽

Cited By ~ 7

Author(s):

Žiga Rotar ◽

◽

Matija Tomšič ◽

Sonja Praprotnik

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Psoriatic Arthritis ◽

Tumour Necrosis ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Factor Α ◽

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-208001 ◽

2015 ◽

Vol 75 (10) ◽

pp. 1757-1762 ◽

Cited By ~ 19

Author(s):

Theresa Wampler Muskardin ◽

Priyanka Vashisht ◽

Jessica M Dorschner ◽

Mark A Jensen ◽

Beverly S Chrabot ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Factor Α ◽

Pretreatment Serum ◽

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis

Central European Journal of Immunology ◽

10.5114/ceji.2019.89601 ◽

2019 ◽

Vol 44 (3) ◽

pp. 269-276 ◽

Cited By ~ 5

Author(s):

Tomasz Kaczyński ◽

Jakub Wroński ◽

Piotr Głuszko ◽

Tomasz Kryczka ◽

Andrzej Miskiewicz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Interleukin 8 ◽

Interleukin 17A ◽

Factor Α ◽

Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(19)30362-0 ◽

2020 ◽

Vol 5 (3) ◽

pp. 276-284 ◽

Cited By ~ 6

Author(s):

Akbar K Waljee ◽

Peter D R Higgins ◽

Camilla B Jensen ◽

Marie Villumsen ◽

Shirley A Cohen-Mekelburg ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Inflammatory Bowel Disease ◽

Cohort Study ◽

Bowel Disease ◽

Tumour Necrosis ◽

Population Based ◽

Inflammatory Bowel ◽

Factor Α ◽

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis

Scientific Reports ◽

10.1038/s41598-019-38670-z ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 6

Author(s):

N. R. Bonetti ◽

C. Diaz-Cañestro ◽

L. Liberale ◽

M. Crucet ◽

A. Akhmedov ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Mouse Model ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Stroke Outcome ◽

Factor Α ◽